Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
37.48
-3.09 (-7.62%)
At close: Oct 10, 2025, 4:00 PM EDT
37.95
+0.47 (1.25%)
After-hours: Oct 10, 2025, 7:58 PM EDT
Harrow Revenue
Harrow had revenue of $63.74M in the quarter ending June 30, 2025, with 30.25% growth. This brings the company's revenue in the last twelve months to $227.66M, up 47.69% year-over-year. In the year 2024, Harrow had annual revenue of $199.61M with 53.32% growth.
Revenue (ttm)
$227.66M
Revenue Growth
+47.69%
P/S Ratio
5.93
Revenue / Employee
$595,971
Employees
382
Market Cap
1.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 199.61M | 69.42M | 53.32% |
Dec 31, 2023 | 130.19M | 41.60M | 46.95% |
Dec 31, 2022 | 88.60M | 16.12M | 22.24% |
Dec 31, 2021 | 72.48M | 23.61M | 48.30% |
Dec 31, 2020 | 48.87M | -2.29M | -4.48% |
Dec 31, 2019 | 51.17M | 9.79M | 23.67% |
Dec 31, 2018 | 41.37M | 14.60M | 54.52% |
Dec 31, 2017 | 26.77M | 6.83M | 34.26% |
Dec 31, 2016 | 19.94M | 10.23M | 105.25% |
Dec 31, 2015 | 9.72M | 8.06M | 485.30% |
Dec 31, 2014 | 1.66M | -8.34M | -83.40% |
Dec 31, 2013 | 10.00M | - | - |
Dec 31, 2012 | - | - | - |
Dec 31, 2011 | - | - | - |
Dec 31, 2010 | - | - | - |
Dec 31, 2009 | - | - | - |
Dec 31, 2008 | - | - | - |
Dec 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
HROW News
- 4 days ago - ImprimisRx Announces Leadership Changes - GlobeNewsWire
- 14 days ago - Harrow, Inc. (HROW) Analyst/Investor Day Transcript - Seeking Alpha
- 14 days ago - Harrow to Acquire Melt Pharmaceuticals - GlobeNewsWire
- 15 days ago - Harrow Launches Harrow Access for All (HAFA) - GlobeNewsWire
- 25 days ago - Harrow Announces Agenda and Speakers for Investor & Analyst Day - GlobeNewsWire
- 4 weeks ago - Harrow: Buy A Blend Of Value And Growth - Seeking Alpha
- 4 weeks ago - Harrow: A Classical GARP Stock - Seeking Alpha
- 4 weeks ago - Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 - GlobeNewsWire